3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
8
Triple Negative Breast Neoplasms
1
Locally Advanced HER2-negative Breast Cancer
1
Hyperthermia
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Interventions
Diathermy
20
Radiotherapy
10
Cisplatin
5
Fluorouracil
4
Drug Therapy
4
Radiation
3
Melphalan
3
Immune Checkpoint Inhibitors
3
Cytoreduction Surgical Procedures
3
Brachytherapy
3
tislelizumab
2
Solutions
2
Immunotherapy
2
Hyperthermia, Induced
2
Hydrogen Peroxide
2
Doxorubicin
2
Conization
2
Capecitabine
2
spartalizumab
1
sodium thiosulfate
1
anlotinib
1
Temozolomide
1
Surgical Procedures, Operative
1
Saline Solution
1
Radiation Dose Hypofractionation
1
Paclitaxel
1
Oxaliplatin
1
Mitomycin
1
Leucovorin
1
Laser Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hyperthermia
×
AC protocol
×
Clear all
NCT05889390
2026-05-15
NeoHTerMa
Semmelweis University
Phase 2/3
Active not recruiting
71 enrolled